1. Show article details.

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

    Benzinga – 8:09 AM ET 05/17/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  2. Show article details.

    24 Stocks Moving in Tuesday's Pre-Market Session

    Benzinga – 6:36 AM ET 05/17/2022

    Don't forget to check out our premarket coverage here .

  3. Show article details.

    AnPac Bio Reports Fiscal Year 2021 Annual Financial Results

    GlobeNewswire – 5:00 PM ET 05/16/2022

    AnPac Bio-Medical Science Co., Ltd., a biotechnology company with operations in China and the United States, announced today its annual financial results for the year ended December 31, 2021. Financial Highlights for Fiscal Year 2021 Non-GAAP net loss is defined as net loss excluding change in fair value of convertible debts and stock-based compensation.

  4. Show article details.

    41 Stocks Moving In Monday's Mid-Day Session

    Benzinga – 12:10 PM ET 05/16/2022

    41 Stocks Moving In Monday's Mid-Day Session

  5. Show article details.

    30 Stocks Moving in Monday's Pre-Market Session

    Benzinga – 6:57 AM ET 05/16/2022

    Don't forget to check out our premarket coverage here .

  6. Show article details.

    99 Biggest Movers From Yesterday

    Benzinga – 4:29 AM ET 05/12/2022

    99 Biggest Movers From Yesterday

  7. Show article details.

    12 Health Care Stocks Moving In Wednesday's Intraday Session

    Benzinga – 1:56 PM ET 05/11/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  8. Show article details.

    AnPac Bio Regains Compliance with Market-Value-Of-Publicly Held Shares Requirement upon Transfer to The Nasdaq Capital Market

    GlobeNewswire – 7:30 AM ET 05/11/2022

    AnPac Bio-Medical Science Co., Ltd. (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that The Nasdaq Stock Market LLC has notified the Company on May 9, 2022, that ANPC’s American Depositary Shares are now in compliance with the maintenance of the minimum market value of publicly held shares of $1,000,000 as a res...

  9. Show article details.

    Nasdaq Hearing Panel Grants AnPac Bio’s Request to Transfer Securities from The Nasdaq Global Market to The Nasdaq Capital Market

    GlobeNewswire – 7:30 AM ET 05/06/2022

    AnPac Bio-Medical Science Co., Ltd. (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that the Nasdaq Hearings Panel has granted the request of AnPac Bio to transfer the Company’s American Depositary Shares from The Nasdaq Global Market to The Nasdaq Capital Market, effective May 6, 2022 and to continue its listing...

  10. Show article details.

    12 Health Care Stocks Moving In Wednesday's After-Market Session

    Benzinga – 5:43 PM ET 05/04/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

  11. Show article details.

    74 Biggest Movers From Yesterday

    Benzinga – 5:19 AM ET 04/29/2022

    74 Biggest Movers From Yesterday

  12. Show article details.

    Stocks That Hit 52-Week Lows On Tuesday

    Benzinga – 1:44 PM ET 04/26/2022

      During Tuesday, 581 stocks hit new 52-week lows. Meta Platforms was the biggest company on a market cap basis to set a new 52-week low. The smallest company by market cap to set a new 52-week low was AnPac Bio-Medical Science. During Tuesday, the following stocks broke to new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  13. Show article details.

    12 Health Care Stocks Moving In Monday's Intraday Session

    Benzinga – 2:16 PM ET 04/25/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  14. Show article details.

    Stocks That Hit 52-Week Lows On Monday

    Benzinga – 12:01 PM ET 04/25/2022

      On Monday, 721 companies achieved new lows for the year. During Monday, the following stocks set new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  15. Show article details.

    Stocks That Hit 52-Week Lows On Friday

    Benzinga – 12:26 PM ET 04/22/2022

      On Friday, 431 companies hit new 52-week lows. Here are all the stocks that set new 52-week lows on Friday: Be sure to stay with Benzinga for further updates and market-moving news.

  16. Show article details.

    AnPac Bio and New Investor Sign Equity Investment Totaling $15 Million

    GlobeNewswire – 7:30 AM ET 04/11/2022

    AnPac Bio-Medical Science Co., Ltd. (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that on April 4, 2022, the Company and Hunan Weitou Technology Co., Ltd. have signed a legally binding equity investment totaling $15 Million which will be invested in five installments over the next 30 months.

  17. Show article details.

    AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board Member

    GlobeNewswire – 9:12 PM ET 04/08/2022

    AnPac Bio-Medical Science Co., Ltd. (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that Dr. Aidong Chen has joined the Company as its board director, Chief Executive Officer and Chairman of the Board of Directors.

  18. Show article details.

    AnPac Bio Filed Request for a Hearing Regarding Continued Listing on NASDAQ, The Hearing was Granted and scheduled for Late April

    GlobeNewswire – 7:30 AM ET 04/04/2022

    AnPac Bio-Medical Science Co., Ltd. (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that on April 1, 2022, the Company received a Nasdaq Hearing Instructions letter from the Nasdaq Stock Market LLC notifying the Company that a Nasdaq Hearings Panel will consider the Company’s appeal at an oral hearing which will ...

  19. Show article details.

    AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

    GlobeNewswire – 12:12 AM ET 03/26/2022

    AnPac Bio-Medical Science Co., Ltd. (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that on March 24, 2022, it received a Staff determination letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company of the Staff’s determination to delist the Company’s securities from ...

  20. Show article details.

    96 Biggest Movers From Yesterday

    Benzinga – 4:51 AM ET 03/15/2022

    96 Biggest Movers From Yesterday

Page:

Today's and Upcoming Events

No events in the next 90 days

Past Events (last 90 days)

  • Nov
    26

    ANPC announced Q3 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.